Results 251 to 260 of about 48,931 (264)

Transepithelial Transport of the Group II Metabotropic Glutamate 2/3 Receptor Agonist (1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY354740) and Its Prodrug (1S,2S,5R,6S)-2-[(2′S)-(2′-Amino)propionyl]aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY544344)

, 2008
Manthena V. S. Varma, André Huss Eriksson, Geri A. Sawada, Y. Anne Pak, E.J. Perkins, Cheryl L. Zimmerman   +5 more
openalex   +1 more source

Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile - (HTL14242)

, 2015
J.A. Christopher, Sarah J. Aves, K.A. Bennett, A.S. Dore, James C. Errey, Ali Jazayeri, Fiona H. Marshall, Krzysztof Okrasa, María J. Serrano‐Vega, B.G. Tehan, Giselle R. Wiggin, Miles Congreve   +11 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Taofeek K Owonikoko, Fadlo R Khuri   +2 more
exaly  

Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile

, 2015
J.A. Christopher, Sarah J. Aves, K.A. Bennett, A.S. Dore, James C. Errey, Ali Jazayeri, Fiona H. Marshall, Krzysztof Okrasa, María J. Serrano‐Vega, B.G. Tehan, Giselle R. Wiggin, Miles Congreve   +11 more
openalex   +1 more source

Advances in Prostate Cancer Chemotherapy: A New Era Begins

Ca-A Cancer Journal for Clinicians, 2005
Kenneth J Pienta, David C Smith
exaly  

Metabotropic Glutamate Receptor in complex with antagonist (1~{S},2~{R},3~{S},4~{S},5~{R},6~{R})-2-azanyl-3-[[3,4-bis(fluoranyl)phenyl]sulfanylmethyl]-4-oxidanyl-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid

, 2016
Mark D. Chappell, R. Li, Stephon C. Smith, Bruce A. Dressman, Eric G. Tromiczak, Allie E. Tripp, Matildes Blanco, Tatiana Vetman, S.J. Quimby, James E. Matt, Tim Ronan Britton, Adam M. Fivush, Jeffrey M. Schkeryantz, Daniel Mayhugh, Jon A. Erickson, Mark G. Bures, Carlos Jaramillo, Mercedes Carpintero, J. Eugenio de Diego, Mario Barberis, Susana García‐Cerrada, José F. Soriano, Stephen Antonysamy, S. Atwell, Iain MacEwan, Bradley Condon, C.A. Bradley, J. Wang, A. Zhang, K. Conners, C. Groshong, S.R. Wasserman, J. Koss, Jeffrey M. Witkin, X. Li, C. Overshiner, Keith A. Wafford, Wesley F. Seidel, X.-S. Wang, B.A. Heinz, S. P. Swanson, John T. Catlow, David W. Bedwell, James A. Monn, Charles H. Mitch, Paul L. Ornstein   +45 more
openalex   +1 more source

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Assignment<footref rid="foot01">¹</footref> of the human metabotropic glutamate receptor gene GRM4 to chromosome 6 band p21.3 by radiation hybrid mapping

, 2000
Alessandro Barbon, Sergio Ferraboli, Sergio Barlati   +2 more
openalex   +1 more source

Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists

, 2000
Atsuro Nakazato, Toshihito Kumagai, Kazunari Sakagami, Ryoko Yoshikawa, Yoshiko Suzuki, Shigeyuki Chaki, Hisanaka Ito, Takeo Taguchi, Shigetada Nakanishi, Shigeru Okuyama   +9 more
openalex   +1 more source

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly